Yvonne S. Gloor

Geneve, GE 1205, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Pharmacogenetic Predictors of Chemotherapy Treatment-Related Toxicities in Paediatric and Adolescent Acute Lymphoblastic Leukemia: A Systematic Review, Meta-Analysis and Literature-Based Candidate Prioritization.

Pharmacogenetic Predictors of Chemotherapy Treatment-Related Toxicities in Paediatric and Adolescent Acute Lymphoblastic Leukemia: A Systematic Review, Meta-Analysis and Literature-Based Candidate Prioritization.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 18, 2026

Cellular pharmacology of fludarabine: molecular determinants of transport and metabolism.

Cellular pharmacology of fludarabine: molecular determinants of transport and metabolism.

Journal: Frontiers in pharmacology

Published: February 26, 2026

Physiologically Based Pharmacokinetic Virtual Twin Approach for Fludarabine Dosing in Pediatric Hematopoietic Stem Cell Transplantation.

Physiologically Based Pharmacokinetic Virtual Twin Approach for Fludarabine Dosing in Pediatric Hematopoietic Stem Cell Transplantation.

Journal: CPT: pharmacometrics & systems pharmacology

Published: December 15, 2025

Refining Busulfan Exposure Enhances Pediatric ALL HSCT Outcomes: Insights from the International FORUM Study.

Refining Busulfan Exposure Enhances Pediatric ALL HSCT Outcomes: Insights from the International FORUM Study.

Journal: Blood advances

Published: November 19, 2025

Refining busulfan exposure enhances pediatric ALL HSCT outcomes: insights from the International FORUM study.

Refining busulfan exposure enhances pediatric ALL HSCT outcomes: insights from the International FORUM study.

Journal: Blood advances

Published: November 19, 2025

IL1B rs1143627 and IL17A rs8193036 in the risk of Acute Graft Versus Host Disease in pediatric HSCT.

IL1B rs1143627 and IL17A rs8193036 in the risk of Acute Graft Versus Host Disease in pediatric HSCT.

Journal: Leukemia research

Published: November 03, 2025

Relationship Between Central Sensitization and Genetic Polymorphisms-A Case-Control Study in Fibromyalgia.

Relationship Between Central Sensitization and Genetic Polymorphisms-A Case-Control Study in Fibromyalgia.

Journal: European journal of pain (London, England)

Published: October 30, 2025

Genetic polymorphisms contributing to hearing loss in children treated with platinum agents: a systematic review and meta-analysis protocol.

Genetic polymorphisms contributing to hearing loss in children treated with platinum agents: a systematic review and meta-analysis protocol.

Journal: BMJ open

Published: September 17, 2025

Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study.

Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study.

Journal: JMIR research protocols

Published: August 23, 2025

Molecular Profiling of SYT-SSX Fusion Transcripts for Enhanced Diagnosis of Synovial Sarcomas.

Molecular Profiling of SYT-SSX Fusion Transcripts for Enhanced Diagnosis of Synovial Sarcomas.

Journal: Journal of personalized medicine

Published: July 28, 2025

HLA-B15:01 and HLA-DRB107:01 as novel markers of acute GVHD in pediatric HSCT.

HLA-B15:01 and HLA-DRB107:01 as novel markers of acute GVHD in pediatric HSCT.

Journal: Bone marrow transplantation

Published: June 04, 2025

Busulfan resistance in AML is associated with changes in mitochondrial copy number and lipid metabolism.

Busulfan resistance in AML is associated with changes in mitochondrial copy number and lipid metabolism.

Journal: Scientific reports

Published: March 25, 2025

Showing 1-12 of 32

Last Updated: 09/26/2026